Table 3.
Injection Drug | FAc Treatments (n=19 eyes) | |||
Pre-FAc | Post-FAc | |||
Eyes N (%) |
Total Treatments | Eyes N (%) |
Total Treatments | |
Any treatment | 19 (100%) | 155 | 9 (47.4%) | 54 |
Anti-VEGF treatments | 17 (89.5%) | 92 | 9 (47.4%) | 52 |
Avastin | 4 (21.1%) | 4 | 0 (0.0%) | 0 |
Lucentis | 8 (42.1%) | 44 | 0 (0.0%) | 0 |
Eylea | 15 (78.9%) | 44 | 9 (47.4%) | 52 |
Steroid treatment | 18 (94.7%) | 37 | 1 (5.3%) | 1 |
Triamcinolone | 0 (0.0%) | 0 | 0 (0.0%) | 0 |
Dexamethasone | 18 (94.7%) | 37 | 1 (5.3%) | 1 |
Focal/Grid laser | 10 (52.6%) | 26 | 1 (5.3%) | 1 |
FAc, fluocinolone acetonide.